Tear lipocalin captures exogenous lipid from abnormal corneal surfaces

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 4, 2010, Pages 1981-1987

  Glasgow, Ben J ^a   Gasymov, Oktay K ^a   Abduragimov, Adil R ^a   Engle, Jamison J ^a   Casey, Richard C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOCALIN; OLEIC ACID; TEAR PROTEIN; CARRIER PROTEIN; EYE PROTEIN; FLUORESCENT DYE; LIPOCALIN 1; MEMBRANE LIPID; TEAR PROTEINS;

ARTICLE; CONTACT ANGLE; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; DRY EYE; FLUORESCENCE SPECTROSCOPY; FLUOROMETRY; GEL FILTRATION CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOPATHY; LIPID ANALYSIS; PRIORITY JOURNAL; RETINA TEAR; STEADY STATE; CORNEA DISEASE; DEBRIDEMENT; FLUOROPHOTOMETRY; GEL CHROMATOGRAPHY; LIPID METABOLISM; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPECTROFLUOROMETRY;

CARRIER PROTEINS; CHROMATOGRAPHY, GEL; CORNEAL DISEASES; DEBRIDEMENT; DRY EYE SYNDROMES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIUM, CORNEAL; EYE PROTEINS; FLUORESCENT DYES; FLUOROPHOTOMETRY; HUMANS; LIPID METABOLISM; LIPOCALIN 1; MEMBRANE LIPIDS; SPECTROMETRY, FLUORESCENCE;

EID: 77951214856     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4622     Document Type: Article

References (56)

1. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res. 2004;78:379-388.
2. Holly FJ, Lemp MA. Wettability and wetting of corneal epithelium. Exp Eye Res. 1971;11:239-250.
3. Holly FJ. Formation and rupture of the tear film. Exp Eye Res. 1973;15:515-525.
4. Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281:12093-12101.
5. Said T, Dutot M, Christon R, et al. Benefits and side effects of different vegetable oil vectors on apoptosis, oxidative stress, and P2X7 cell death receptor activation. Invest Ophthalmol Vis Sci. 2007;48:5000-5006.
6. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids-a review. Curr Eye Res. 2008;33:405-420.
7. Borchman D, Foulks GN, Yappert MC, Mathews J, Leake K, Bell J. Factors affecting evaporation rates of tear film components measured in vitro. Eye Contact Lens. 2009;35:32-37.
8. Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990;31:1119-1126.
9. Glasgow BJ, Abduragimov AR, Farahbakhsh ZT, Faull KF, Hubbell WL. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res. 1995;14:363-372.
10. Gasymov OK, Abduragimov AR, Glasgow BJ. Evidence for internal and external binding sites on human tear lipocalin. Arch Biochem Biophys. 2007;468:15-21.
11. Gasymov OK, Abduragimov AR, Glasgow BJ. Ligand binding site of tear lipocalin: contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid. Biochemistry. 2008;47:1414-1424.
12. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Resolution of ligand positions by site-directed tryptophan fluorescence in tear lipocalin. Protein Sci. 2000;9:325-331.
13. Gasymov OK, Abduragimov AR, Glasgow BJ. Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence. Biochemistry. 2009;48:7219-7228.
14. Gasymov OK, Abduragimov AR, Prasher P, Yusifov TN, Glasgow BJ. Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface. Invest Ophthalmol Vis Sci. 2005;46:3589-3596.
15. Glasgow BJ, Gasymov OK, Casey RC. Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 glyocalyx. Invest Ophthalmol Vis Sci. 2009;50:4060-4064.
16. Chen W, Zhang X, Zhang J, et al. A murine model of dry eye induced by an intelligently controlled environmental system. Invest Ophthalmol Vis Sci. 2008;49:1386-1391.
17. De Paiva CS, Corrales RM, Villarreal AL, et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci. 2006; 47:2847-2856.
18. Sjogren H. Zur kenntnis der keratoconjunctivitis sicca. Acta Ophthalmol (Copenh). 1933;1(suppl 11):151.
19. Glasgow BJ. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefes Arch Clin Exp Ophthalmol. 1995;233:513-522.
20. Glasgow B, Foos, RY. Ocular Cytopathology. Stoneham, MA: Butterworth-Heinemann; 1993:1-3.
21. Glasgow BJ, Marshall G, Gasymov OK, Abduragimov AR, Yusifov TN, Knobler CM. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci. 1999;40:3100-3107.
22. Querinjean P, Masson PL, Heremans JF. Molecular weight, singlechain structure and amino acid composition of human lactoferrin. Eur J Biochem. 1971;20:420-425.
23. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Sitedirected tryptophan fluorescence reveals the solution structure of tear lipocalin: evidence for features that confer promiscuity in ligand binding. Biochemistry. 2001;40:14754-14762.
24. Lim WH, Lawrence MJ. Aggregation behavior of mixtures of phosphatidylcholine and polyoxyethylene sorbitan monoesters in aqueous solution. Phys Chem Chem Phys. 2004;6:1380-1387.
25. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 5th ed. New York: John Wiley & Sons; 1991:209-215.
26. Tiffany JM. Measurement of wettability of the corneal epithelium, II: contact angle method. Acta Ophthalmol (Copenh). 1990;68: 182-187.
27. Tiffany JM. Measurement of wettability of the corneal epithelium, I: particle attachment method. Acta Ophthalmol (Copenh). 1990; 68:175-181.
28. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures: 1996-2000. Cornea. 2002;21:148-151.
29. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea. 2000;19:813-816.
30. Chen WL, Hu FR, Wang IJ. Changing indications for penetrating keratoplasty in Taiwan from 1987 to 1999. Cornea. 2001;20:141-144.
31. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada: 1986-1995. Cornea. 1997;16:414-419.
32. Narayanan R, Gaster RN, Kenney MC. Pseudophakic corneal edema: a review of mechanisms and treatments. Cornea. 2006;25: 993-1004.
33. Taylor DM, Atlas BF, Romanchuk KG, Stern AL. Pseudophakic bullous keratopathy. Ophthalmology. 1983;90:19-24.
34. Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM. Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy. Br J Ophthalmol. 2001;85:720-731.
35. Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas. J Histochem Cytochem. 2001; 49:1341-1350.
36. Beardsley RM, De Paiva CS, Power DF, Pflugfelder SC. Desiccating stress decreases apical corneal epithelial cell size-modulation by the metalloproteinase inhibitor doxycycline. Cornea. 2008;27: 935-940.
37. Chen JJ, Rao K, Pflugfelder SC. Corneal epithelial opacity in dysfunctional tear syndrome. Am J Ophthalmol. 2009;148:376-382.
38. Argueso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci. 2003;44:2487-2495.
39. Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998;39:2602-2609.
40. Eagle RC Jr, Laibson PR, Arentsen JJ. Epithelial abnormalities in chronic corneal edema: a histopathological study. Trans Am Ophthalmol Soc. 1989;87:107-119; discussion 119-124.
41. Ozyildirim AM, Wistow GJ, Gao J, et al. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Invest Ophthalmol Vis Sci. 2005;46: 1572-1580.
42. Saaren-Seppala H, Jauhiainen M, Tervo TM, Redl B, Kinnunen PK, Holopainen JM. Interaction of purified tear lipocalin with lipid membranes. Invest Ophthalmol Vis Sci. 2005;46:3649-3656.
43. Jauhiainen M, Setala NL, Ehnholm C, et al. Phospholipid transfer protein is present in human tear fluid. Biochemistry. 2005;44: 8111-8116.
44. Glasgow B, Gasymov OK. Lipocalin versus phospholipid transfer protein as the major lipid carrier in tears (E-Letter). Invest Ophthalmol Vis Sci. 2006.
45. Gasymov OK, Abduragimov AR, Merschak P, Redl B, Glasgow BJ. Oligomeric state of lipocalin-1 (LCN1) by multiangle laser light scattering and fluorescence anisotropy decay. Biochim Biophys Acta. 2007;1774:1307-1315.
46. Redl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilicligand carrier protein superfamily. J Biol Chem. 1992;267:20282-20287.
47. Athappilly GK, Braverman RS. Congenital alacrima in a patient with blepharophimosis syndrome. Ophthalmic Genet. 2009;30: 37-39.
48. Gazda MJ, Schultheiss TE, Stephens LC, Ang KK, Peters LJ. The relationship between apoptosis and atrophy in the irradiated lacrimal gland. Int J Radiat Oncol Biol Phys. 1992;24:693-697.
49. Rong Z, Zixiang Y, Chang L, et al. Lacrimal hyposecretion: a surgical complication of juvenile nasopharyngeal angiofibroma. Am J Otolaryngol. 2008;29:367-371.
50. Ang RT, Dartt DA, Tsubota K. Dry eye after refractive surgery. Curr Opin Ophthalmol. 2001;12:318-322.
51. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.
52. Haugen AJ, Peen E, Hulten B, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol. 2008;37:30-34.
53. Williamson J, Gibson AA, Wilson T, Forrester JV, Whaley K, Dick WC. Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol. 1973;57:852-858.
54. Janssen PT, van Bijsterveld OP. Tear fluid proteins in Sjogren's syndrome. Scand J Rheumatol Suppl. 1986;61:224-227.
55. Schoenwald RD, Vidvauns S, Wurster DE, Barfknecht CF. Tear film stability of protein extracts from dry eye patients administered a sigma agonist. J Ocul Pharmacol Ther. 1997;13:151-161.
56. Caffery B, Joyce E, Boone A, et al. Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom Vis Sci. 2008;85:661-667.